Ethics declarations : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study
Ethics declarations : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study
author: Heidi Andersen, Anne Merete Aass, Johan Caspar Wohlfahrt | publisher: drg. Andreas Tjandra, Sp. Perio, FISID
The present study was approved by the Regional Committee for Medical and Health Research Ethics, South East Norway (REK 2015/90). A writen informed consent was signed by all study participants
Dr. Johan Caspar Wohlfahrt has received lecture fees from the producers of the material used in the study and is a previous shareholder in the company (Tigran AB, Malmoe, Sweden). Heidi Andersen and Anne Merete Aass state that they have no competing interests related to the study. During the undertaking of the long-term follow-up, none of the authors received financial reimbursement or lecture fees from any companies related to methods used in the study.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Serial posts:
- Abstract : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study
- Findings : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study [1]
- Findings : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study [2]
- Findings : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study [3]
- Findings : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study [4]
- Findings : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study [5]
- Findings : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study [6]
- Findings : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study [7]
- Findings : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study [8]
- Findings : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study [9]
- Findings : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study [10]
- References : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study [1]
- References : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study [2]
- References : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study [3]
- Acknowledgements : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study
- Author information : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study
- Ethics declarations : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study
- Rights and permissions : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study
- About this article : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study
- Table 1 Characteristics of the subjects at the 7-year follow-up : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study
- Table 2 Data at baseline, 12 months and 7 years for the PTG and OFD groups : Porous titanium granules in the treatment of peri-implant osseous defects—a 7-year follow-up study
- Fig. 1. Consort flowchart : Porous titanium granules in the treatment of peri-implant
- Fig. 2. PTG observed in radiographs at the 8-year follow-up : Porous titanium granules in the treatment of peri-implant